Stoke Therapeutics, Inc. (STOK)
NASDAQ: STOK · Real-Time Price · USD
30.96
+1.15 (3.86%)
At close: Dec 3, 2025, 4:00 PM EST
30.96
0.00 (0.00%)
After-hours: Dec 3, 2025, 4:38 PM EST

Stoke Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
1,7685842353648832,244
Upgrade
Market Cap Growth
177.52%148.73%-35.46%-58.77%-60.67%142.11%
Upgrade
Enterprise Value
1,437320231186522,054
Upgrade
Last Close Price
29.8111.035.269.2323.9961.93
Upgrade
PS Ratio
8.4015.9826.7529.34--
Upgrade
PB Ratio
5.332.551.471.974.057.84
Upgrade
P/TBV Ratio
5.722.551.471.974.057.84
Upgrade
EV/Sales Ratio
6.998.762.679.51--
Upgrade
Debt / Equity Ratio
0.020.020.040.030.020.00
Upgrade
Asset Turnover
0.630.150.040.05--
Upgrade
Quick Ratio
6.215.436.547.3312.8325.15
Upgrade
Current Ratio
6.535.816.997.7713.3725.73
Upgrade
Return on Equity (ROE)
15.02%-45.80%-60.80%-50.20%-34.06%-20.47%
Upgrade
Return on Assets (ROA)
5.20%-25.35%-29.62%-26.36%-20.04%-12.59%
Upgrade
Return on Capital (ROIC)
6.18%-31.66%-40.26%-31.61%-21.09%-12.96%
Upgrade
Return on Capital Employed (ROCE)
8.50%-43.80%-58.10%-46.40%-38.80%-18.50%
Upgrade
Earnings Yield
2.30%-15.23%-44.58%-27.77%-9.72%-2.33%
Upgrade
FCF Yield
2.97%-14.90%-35.20%-9.84%-7.72%-1.93%
Upgrade
Buyback Yield / Dilution
-16.83%-22.76%-13.11%-5.87%-9.71%-86.34%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q